NO20012716D0 - Terapeutisk middel for undertrykkelse av snorkelyder - Google Patents

Terapeutisk middel for undertrykkelse av snorkelyder

Info

Publication number
NO20012716D0
NO20012716D0 NO20012716A NO20012716A NO20012716D0 NO 20012716 D0 NO20012716 D0 NO 20012716D0 NO 20012716 A NO20012716 A NO 20012716A NO 20012716 A NO20012716 A NO 20012716A NO 20012716 D0 NO20012716 D0 NO 20012716D0
Authority
NO
Norway
Prior art keywords
bont
clostridium toxin
carrier
added
therapeutic agent
Prior art date
Application number
NO20012716A
Other languages
English (en)
Other versions
NO20012716L (no
NO328762B1 (no
Inventor
Hans Bigalke
Juergen Frevert
Original Assignee
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh filed Critical Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh
Publication of NO20012716D0 publication Critical patent/NO20012716D0/no
Publication of NO20012716L publication Critical patent/NO20012716L/no
Publication of NO328762B1 publication Critical patent/NO328762B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20012716A 1998-12-10 2001-06-01 Anvendelse av klostridiumtoksin eller kompleks derav for fremstilling av et terapeutisk middel NO328762B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19856897A DE19856897A1 (de) 1998-12-10 1998-12-10 Therapeutikum zur Unterdrückung von Schnarchgeräuschen
PCT/EP1999/009791 WO2000033863A2 (de) 1998-12-10 1999-12-10 Therapeutikum zur unterdrückung von schnarchgeräuschen

Publications (3)

Publication Number Publication Date
NO20012716D0 true NO20012716D0 (no) 2001-06-01
NO20012716L NO20012716L (no) 2001-06-01
NO328762B1 NO328762B1 (no) 2010-05-10

Family

ID=7890562

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20012716A NO328762B1 (no) 1998-12-10 2001-06-01 Anvendelse av klostridiumtoksin eller kompleks derav for fremstilling av et terapeutisk middel

Country Status (21)

Country Link
US (1) US6573241B1 (no)
EP (1) EP1137430B1 (no)
JP (1) JP4700811B2 (no)
KR (1) KR100859556B1 (no)
CN (1) CN1186095C (no)
AT (1) ATE234108T1 (no)
AU (1) AU764744B2 (no)
BR (1) BR9915800A (no)
CA (1) CA2353469A1 (no)
CZ (1) CZ295769B6 (no)
DE (2) DE19856897A1 (no)
DK (1) DK1137430T3 (no)
ES (1) ES2192880T3 (no)
HK (1) HK1040636B (no)
HU (1) HUP0104702A3 (no)
IL (2) IL143528A0 (no)
NO (1) NO328762B1 (no)
PL (1) PL202908B1 (no)
PT (1) PT1137430E (no)
RU (1) RU2243783C2 (no)
WO (1) WO2000033863A2 (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
US20080038274A1 (en) 1999-09-23 2008-02-14 Foster Keith A Inhibition of secretion from non-neuronal cells
DE10035156A1 (de) * 2000-07-19 2002-02-07 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Proteinkomplex als Vehikel für oral verfügbare Protein-Arzneimittel
US20100104631A1 (en) * 2001-08-13 2010-04-29 Lipella Pharmaceuticals Inc. Method of treatment for bladder dysfunction
US7763663B2 (en) * 2001-12-19 2010-07-27 University Of Massachusetts Polysaccharide-containing block copolymer particles and uses thereof
US7691394B2 (en) * 2002-05-28 2010-04-06 Botulinum Toxin Research Associates, Inc. High-potency botulinum toxin formulations
US20040009180A1 (en) * 2002-07-11 2004-01-15 Allergan, Inc. Transdermal botulinum toxin compositions
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
CA2518650A1 (en) * 2004-09-10 2006-03-10 Dimitrios Dimitrakoudis Clostridium botulinum toxin formulation and method for reducing weight
WO2006138127A2 (en) * 2005-06-14 2006-12-28 Botulinum Toxin Research Associates, Inc. Botulinum toxin and the treatment of primary disorders of mood and affect
US8926991B2 (en) 2005-06-14 2015-01-06 Botulinum Toxin Research Associates, Inc. Botulinum toxin and the treatment of primary disorders of mood and affect
US20150258183A1 (en) 2006-06-07 2015-09-17 Botulinum Toxin Research Associates, Inc. Botulinum Toxin and the Treatment of Primary Disorders of Mood and Affect
CA2618655C (en) 2005-07-18 2015-12-22 University Of Massachusetts Lowell Compositions and methods for making and using nanoemulsions
US9486408B2 (en) 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
DK3144013T3 (en) 2005-12-01 2019-03-04 Univ Massachusetts Lowell Botulinum nanoemulsions
US10792344B2 (en) 2006-06-29 2020-10-06 Merz Pharma Gmbh & Co. Kgaa High frequency application of botulinum toxin therapy
AR061669A1 (es) 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa Aplicacion de alta frecuencia de terapia con toxina botulinica
BRPI0719756A2 (pt) * 2006-12-01 2014-01-21 Anterios Inc Nanopartículas de entidades anfifílicas
BRPI0719732A2 (pt) 2006-12-01 2017-05-16 Anterios Inc nanopartículas de peptídeo e usos para as mesmas
KR20100050443A (ko) 2007-05-31 2010-05-13 안테리오스, 인코퍼레이티드 핵산 나노입자 및 이의 용도
CN105147608B (zh) * 2008-06-26 2019-12-10 安特里奥公司 真皮递送
WO2010096134A1 (en) 2008-12-04 2010-08-26 Botulinum Toxin Research Associates, Inc. Extended length botulinum toxin formulation for human or mammalian use
US20100166739A1 (en) * 2008-12-30 2010-07-01 Lipella Paharmaceuticals Inc. Methods and Compositions for Diagnosing Urological Disorders
JP2013510193A (ja) * 2009-11-09 2013-03-21 サンダース，イラ 神経毒を用いる睡眠呼吸障害の処置
EP2677029B1 (en) 2011-05-19 2017-05-10 Ipsen Bioinnovation Limited Methods for the manufacture of proteolytically processed polypeptides
US9393291B2 (en) 2012-04-12 2016-07-19 Botulinum Toxin Research Associates, Inc. Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
JP6156954B2 (ja) 2012-11-21 2017-07-05 イプセン バイオイノベーション リミテッド タンパク分解性にプロセシングされたポリペプチドの製造方法
GB201407525D0 (en) 2014-04-29 2014-06-11 Syntaxin Ltd Manufacture of recombinant clostridium botulinum neurotoxins
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US9901627B2 (en) 2014-07-18 2018-02-27 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease
US11311496B2 (en) 2016-11-21 2022-04-26 Eirion Therapeutics, Inc. Transdermal delivery of large agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4551473A (en) * 1984-04-26 1985-11-05 Schossow George W Method of inhibiting snoring and obstructive sleep apnea
CA2138020C (en) * 1992-06-23 1999-02-16 Eric A. Johnson Pharmaceutical composition containing botulinum b complex
AU683275B2 (en) * 1993-06-10 1997-11-06 Allergan, Inc. Multiple botulinum toxins for treating neuromuscular disorders and conditions
EP1598077B1 (en) * 1993-12-28 2009-11-04 Allergan, Inc. Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle
US5512547A (en) * 1994-10-13 1996-04-30 Wisconsin Alumni Research Foundation Pharmaceutical composition of botulinum neurotoxin and method of preparation
US5756468A (en) * 1994-10-13 1998-05-26 Wisconsin Alumni Research Foundation Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
US5721215A (en) * 1996-03-20 1998-02-24 Allergan Injectable therapy for control of muscle spasms and pain related to muscle spasms
US9354569B2 (en) 2013-06-13 2016-05-31 Lexmark International, Inc. Heat transfer system for a fuser assembly

Also Published As

Publication number Publication date
HUP0104702A2 (hu) 2002-04-29
IL143528A0 (en) 2002-04-21
PL202908B1 (pl) 2009-08-31
BR9915800A (pt) 2001-09-25
PL349334A1 (en) 2002-07-15
JP2002531516A (ja) 2002-09-24
CZ295769B6 (cs) 2005-11-16
HUP0104702A3 (en) 2003-09-29
US6573241B1 (en) 2003-06-03
DK1137430T3 (da) 2003-06-16
JP4700811B2 (ja) 2011-06-15
ATE234108T1 (de) 2003-03-15
AU3037400A (en) 2000-06-26
HK1040636B (zh) 2003-05-30
WO2000033863A2 (de) 2000-06-15
CN1329501A (zh) 2002-01-02
DE59904569D1 (de) 2003-04-17
ES2192880T3 (es) 2003-10-16
CZ20012058A3 (cs) 2001-09-12
KR100859556B1 (ko) 2008-09-22
AU764744B2 (en) 2003-08-28
WO2000033863A3 (de) 2000-11-02
RU2243783C2 (ru) 2005-01-10
EP1137430B1 (de) 2003-03-12
PT1137430E (pt) 2003-07-31
EP1137430A2 (de) 2001-10-04
CN1186095C (zh) 2005-01-26
HK1040636A1 (en) 2002-06-21
NO20012716L (no) 2001-06-01
DE19856897A1 (de) 2000-06-15
KR20010089527A (ko) 2001-10-06
IL143528A (en) 2008-04-13
NO328762B1 (no) 2010-05-10
CA2353469A1 (en) 2000-06-15

Similar Documents

Publication Publication Date Title
NO20012716D0 (no) Terapeutisk middel for undertrykkelse av snorkelyder
MX9706095A (es) Enzima multifuncional.
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
WO2004110472A3 (en) Fusion proteins
WO2001034646A3 (en) Recombinant gelatins
SE9503143D0 (sv) New preparation
ATE552891T1 (de) Kombination von sauren-proteaseenzymen und sauren pufferlösungen sowie deren verwendung
MX9702349A (es) Usos de derivado de 9-deoxi prostaglandina para tratar glaucoma.
WO2001007432A8 (en) Aminopiperidine derivatives as antibacterials
AU6549898A (en) Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina
AU1917095A (en) 6-substituted mycophenolic and derivatives with immunosuppressive activity
RU2001116080A (ru) Терапевтический агент для подавления шумов храпа
DE69826684D1 (de) Kovalent gebundenes n,o-carboxymethylchitosan und seine verwendungen
CA2253287A1 (en) A process for producing a recombinant polypeptide involving the addition of an inhibitor of metal-dependent proteases or chymotrypsins to the cell culture medium
WO2000018316A3 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
WO2002038775A3 (en) METHODS FOR PRODUCING AND PURIFYING RECOMBINANT α-L-IDURONIDASE
TR199900770T2 (xx) Nazal poliplerin tedavisinde bir H+, K+-ATPase'�n kullan�lmas�.
CA2251132A1 (en) Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
AU4985596A (en) Novel aroylaniline derivatives, compositions and uses thereof in the treatment of viral infections
AU1041397A (en) Antigenic protein originating in malassezia
MXPA03007992A (es) Composicion farmaceutica de fragmentos f(ab)2 de anticuerpos y un proceso para su preparacion
DE69635806D1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
AU7315596A (en) Pharmaceutical composition for topical application
ES2116078T3 (es) 4-aminoderivados de acido micofenolico 5-sustituido.
AU2001226361A1 (en) Pharmaceutical composition and method of using the same

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees